Holdings
Vitality Portfolio
As of Mar 31, 2026, Vitality Portfolio reported 31 positions worth US$1.95M. Largest: Argenx Se, Eli Lilly And Company and Ascendis Pharma A/s. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Argenx Se | 235 | US$172K | first report | Mar 31, 2026 |
| Eli Lilly And Company | 181 | US$166K | first report | Mar 31, 2026 |
| Ascendis Pharma A/s | 512 | US$117K | first report | Mar 31, 2026 |
| Nektar Therapeutics | 1,412 | US$102K | first report | Mar 31, 2026 |
| Thermo Fisher Scientific Inc | 186 | US$91,425 | first report | Mar 31, 2026 |
| Align Technology, Inc. | 521 | US$89,315 | first report | Mar 31, 2026 |
| Enliven Therapeutics, Inc. | 2,126 | US$83,339 | first report | Mar 31, 2026 |
| 10x Genomics, Inc. | 3,801 | US$80,695 | first report | Mar 31, 2026 |
| Newamsterdam Pharma Company N.v. | 2,383 | US$76,280 | first report | Mar 31, 2026 |
| Ceribell, Inc. | 3,915 | US$71,762 | first report | Mar 31, 2026 |